Joseph A Vetro, PhD

Assistant Professor, Pharmaceutical Science
Member, Fred & Pamela Buffett Cancer Center

Phone402-559-9359

Source: Scopus
Calculated based on no. of publications stored in Pure and citations from Scopus

Research activity per year

If you made any changes in Pure these will be visible here soon.

Fingerprint

Dive into the research topics where Joseph A Vetro is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

0 Similar Profiles

Network

Recent external collaboration on country level. Dive into details by clicking on the dots.

1 Active
4 Finished

Host-Directed Immunotherapy: A One Health Approach
Sanderson, S. & Vetro, J. A.
National Institutes of Health
7/7/16 → 6/30/21
Project: Research project
Development of Chol-DsiRNA Polyplexes to Improve the Therapy of Breast Cancer
Vetro, J. A.
National Institutes of Health
9/15/16 → 8/31/17
Project: Research project
EP67-Based Targeted Mucosal Vaccines to Prevent Primary Infection with CMV
Vetro, J. A.
National Institutes of Health
2/1/16 → 1/31/21
Project: Research project
Nebraska Center for Nanomedicine
Vetro, J. A., Boska, M. D., Zimmerman, M. C., Poluektova, L. Y., Kabanov, A., Huanyu, D. & Batrakova, E.
National Institutes of Health
9/26/08 → 6/30/13
Project: Research project
Development of Targeted Nanogels for siRNA Delivery to Tumor Vasculature
Vetro, J. A.
National Institutes of Health
8/1/07 → 7/31/10
Project: Research project

519 Citations
10 h-Index
15 Article
2 Chapter
2 Comment/debate

Targeted Amino Acid Substitution Overcomes Scale-Up Challenges with the Human C5a-Derived Decapeptide Immunostimulant EP67
Alshammari, A. M., Smith, D. D., Parriott, J., Stewart, J. P., Curran, S. M., McCulloh, R. J., Barry, P. A., Iyer, S. S., Palermo, N., Phillips, J. A., Dong, Y., Ronning, D. R., Vennerstrom, J. L., Sanderson, S. D. & Vetro, J. A., May 8 2020, In: ACS infectious diseases. 6, 5, p. 1169-1181 13 p.
Research output: Contribution to journal › Article › peer-review
Surface conjugation of EP67 to biodegradable nanoparticles increases the generation of long-lived mucosal and systemic memory T-cells by encapsulated protein vaccine after respiratory immunization and subsequent T-cell-mediated protection against respiratory infection
Tallapaka, S. B., Karuturi, B. V. K., Yeapuri, P., Curran, S. M., Sonawane, Y. A., Phillips, J. A., David Smith, D., Sanderson, S. D. & Vetro, J. A., Jun 30 2019, In: International journal of pharmaceutics. 565, p. 242-257 16 p.
Research output: Contribution to journal › Article › peer-review
1 Scopus citations
Complexation of Chol-DsiRNA in place of Chol-siRNA greatly increases the duration of mRNA suppression by polyplexes of PLL(30)-PEG(5K) in primary murine syngeneic breast tumors after i.v. administration
Ambardekar, V. V., Wakaskar, R. R., Ye, Z., Curran, S. M., McGuire, T. R., Coulter, D. W., Singh, R. K. & Vetro, J. A., May 30 2018, In: International journal of pharmaceutics. 543, 1-2, p. 130-138 9 p.
Research output: Contribution to journal › Article › peer-review
1 Scopus citations
Encapsulation of an EP67-Conjugated CTL Peptide Vaccine in Nanoscale Biodegradable Particles Increases the Efficacy of Respiratory Immunization and Affects the Magnitude and Memory Subsets of Vaccine-Generated Mucosal and Systemic CD8⁺ T Cells in a Diameter-Dependent Manner
Karuturi, B. V. K., Tallapaka, S. B., Yeapuri, P., Curran, S. M., Sanderson, S. D. & Vetro, J. A., May 1 2017, In: Molecular Pharmaceutics. 14, 5, p. 1469-1481 13 p.
Research output: Contribution to journal › Article › peer-review
5 Scopus citations
New generation of adjuvants for protection against disease and to combat bioterrorism
Sanderson, S. D., Vetro, J. A. & Karuturi, B. V. K., Jan 1 2016, Neuroimmune Pharmacology. Springer International Publishing, p. 819-830 12 p.
Research output: Chapter in Book/Report/Conference proceeding › Chapter